{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:11:41Z","timestamp":1789143101517,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,11]]},"DOI":"10.7759\/cureus.116102","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:41:59Z","timestamp":1789141319000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of the Hepatorenal Index in the Detection of HbA1c-Defined Dysglycemia in Patients With Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Geethu","family":"Divakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarin","family":"Vidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrah Fathima","family":"Karimbanakkal Edakkattu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisar","family":"Karekadavath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al.. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023, 78:1966-86. 10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver","year":"2024","unstructured":"European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024, 81:492-542. 10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher G","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021, 18:599-612. 10.1038\/s41575-021-00448-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.6677","article-title":"Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis","volume":"199","author":"Marshall RH","year":"2012","unstructured":"Marshall RH, Eissa M, Bluth EI, Gulotta PM, Davis NK. Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis. AJR Am J Roentgenol. 2012, 199:997-1002. 10.2214\/AJR.11.6677","journal-title":"AJR Am J Roentgenol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.22382","article-title":"Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis","volume":"44","author":"Chauhan A","year":"2016","unstructured":"Chauhan A, Sultan LR, Furth EE, Jones LP, Khungar V, Sehgal CM. Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis. J Clin Ultrasound. 2016, 44:580-6. 10.1002\/jcu.22382","journal-title":"J Clin Ultrasound"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255768","article-title":"Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard","volume":"16","author":"Tran BV","year":"2021","unstructured":"Tran BV, Ujita K, Taketomi-Takahashi A, Hirasawa H, Suto T, Tsushima Y. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard. PLoS One. 2021, 16:e0255768. 10.1371\/journal.pone.0255768","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081443","article-title":"Ultrasound stratification of hepatic steatosis using the hepatorenal index","volume":"11","author":"Johnson SI","year":"2021","unstructured":"Johnson SI, Fort D, Shortt KJ, Therapondos G, Galliano GE, Nguyen T, Bluth EI. Ultrasound stratification of hepatic steatosis using the hepatorenal index. Diagnostics (Basel). 2021, 11:1443. 10.3390\/diagnostics11081443","journal-title":"Diagnostics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-019-01009-7","article-title":"The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease","volume":"39","author":"Avramovski P","year":"2020","unstructured":"Avramovski P, Avramovska M, Nikleski Z, Ilkovska B, Sotiroski K, Sikole E. The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease. Indian J Gastroenterol. 2020, 39:50-9. 10.1007\/s12664-019-01009-7","journal-title":"Indian J Gastroenterol"},{"key":"ref10","article-title":"Sample size calculation in medical studies","volume":"6","author":"Pourhoseingholi MA","year":"2013","unstructured":"Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013, 6:14-7.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S002","article-title":"Diagnosis and classification of diabetes: standards of care in diabetes-2026","volume":"49","author":"American Diabetes Association Professional Practice Committee","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: standards of care in diabetes-2026. Diabetes Care. 2026, 49:S27-49. 10.2337\/dc26-S002","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007, 4:e296. 10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i22.3548","article-title":"Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients","volume":"29","author":"Collin R","year":"2023","unstructured":"Collin R, Magnin B, Gaillard C, Nicolas C, Abergel A, Buchard B. Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients. World J Gastroenterol. 2023, 29:3548-60. 10.3748\/wjg.v29.i22.3548","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1148\/rg.220178","article-title":"Quantitative ultrasound for liver fat: past, present, and future","volume":"43","author":"Fetzer DT","year":"2023","unstructured":"Fetzer DT, Pierce TT, Robbin ML, et al.. Quantitative ultrasound for liver fat: past, present, and future. Radiographics. 2023, 43:e220178. 10.1148\/rg.220178","journal-title":"Radiographics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s40608-016-0118-0","article-title":"Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects","volume":"3","author":"Isaksen VT","year":"2016","unstructured":"Isaksen VT, Larsen MA, Goll R, Florholmen JR, Paulssen EJ. Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects. BMC Obes. 2016, 3:39. 10.1186\/s40608-016-0118-0","journal-title":"BMC Obes"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-11774-z","article-title":"Ultrasound hepatorenal index for the diagnosis of steatosis in patients with type 2 diabetes: a prospective validation study","volume":"35","author":"Hamadouche M","year":"2025","unstructured":"Hamadouche M, Vilgrain V, Hobeika C, et al.. Ultrasound hepatorenal index for the diagnosis of steatosis in patients with type 2 diabetes: a prospective validation study. Eur Radiol. 2025, 35:7927-39. 10.1007\/s00330-025-11774-z","journal-title":"Eur Radiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103645","article-title":"Effects of glucagon-like peptide-1 receptor agonists on alcohol consumption: a systematic review and meta-analysis","volume":"90","author":"Eshraghi R","year":"2025","unstructured":"Eshraghi R, Ghadimi DJ, Montazerinamin S, et al.. Effects of glucagon-like peptide-1 receptor agonists on alcohol consumption: a systematic review and meta-analysis. EClinicalMedicine. 2025, 90:103645. 10.1016\/j.eclinm.2025.103645","journal-title":"EClinicalMedicine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/522516-role-of-the-hepatorenal-index-in-the-detection-of-hba1c-defined-dysglycemia-in-patients-with-non-alcoholic-fatty-liver-disease-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:42:00Z","timestamp":1789141320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/522516-role-of-the-hepatorenal-index-in-the-detection-of-hba1c-defined-dysglycemia-in-patients-with-non-alcoholic-fatty-liver-disease-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.116102","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}